187 related articles for article (PubMed ID: 18180300)
1. Opacity factor activity and epithelial cell binding by the serum opacity factor protein of Streptococcus pyogenes are functionally discrete.
Gillen CM; Courtney HS; Schulze K; Rohde M; Wilson MR; Timmer AM; Guzman CA; Nizet V; Chhatwal GS; Walker MJ
J Biol Chem; 2008 Mar; 283(10):6359-66. PubMed ID: 18180300
[TBL] [Abstract][Full Text] [Related]
2. Serum opacity factor promotes group A streptococcal epithelial cell invasion and virulence.
Timmer AM; Kristian SA; Datta V; Jeng A; Gillen CM; Walker MJ; Beall B; Nizet V
Mol Microbiol; 2006 Oct; 62(1):15-25. PubMed ID: 16942605
[TBL] [Abstract][Full Text] [Related]
3. Intranasal immunization with serum opacity factor (SOF) of Streptococcus pyogenes fails to protect mice against lethal mucosal challenge with a heterologous strain.
Schulze K; Medina E; Guzmán CA
Vaccine; 2006 Feb; 24(9):1446-50. PubMed ID: 16289766
[TBL] [Abstract][Full Text] [Related]
4. Immunological response mounted by Aboriginal Australians living in the Northern Territory of Australia against Streptococcus pyogenes serum opacity factor.
Gillen CM; Towers RJ; McMillan DJ; Delvecchio A; Sriprakash KS; Currie B; Kreikemeyer B; Chhatwal GS; Walker MJ
Microbiology (Reading); 2002 Jan; 148(Pt 1):169-78. PubMed ID: 11782509
[TBL] [Abstract][Full Text] [Related]
5. FbsC, a novel fibrinogen-binding protein, promotes Streptococcus agalactiae-host cell interactions.
Buscetta M; Papasergi S; Firon A; Pietrocola G; Biondo C; Mancuso G; Midiri A; Romeo L; Teti G; Speziale P; Trieu-Cuot P; Beninati C
J Biol Chem; 2014 Jul; 289(30):21003-21015. PubMed ID: 24904056
[TBL] [Abstract][Full Text] [Related]
6. Function of the fibronectin-binding serum opacity factor of Streptococcus pyogenes in adherence to epithelial cells.
Oehmcke S; Podbielski A; Kreikemeyer B
Infect Immun; 2004 Jul; 72(7):4302-8. PubMed ID: 15213180
[TBL] [Abstract][Full Text] [Related]
7. Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.
Courtney HS; Hasty DL; Dale JB
Infect Immun; 2003 Sep; 71(9):5097-103. PubMed ID: 12933852
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.
Pandey M; Mortensen R; Calcutt A; Powell J; Batzloff MR; Dietrich J; Good MF
J Immunol; 2016 Apr; 196(8):3364-74. PubMed ID: 26969753
[TBL] [Abstract][Full Text] [Related]
9. Serum opacity factor is a major fibronectin-binding protein and a virulence determinant of M type 2 Streptococcus pyogenes.
Courtney HS; Hasty DL; Li Y; Chiang HC; Thacker JL; Dale JB
Mol Microbiol; 1999 Apr; 32(1):89-98. PubMed ID: 10216862
[TBL] [Abstract][Full Text] [Related]
10. Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation.
Olive C; Schulze K; Sun HK; Ebensen T; Horváth A; Toth I; Guzman CA
Vaccine; 2007 Feb; 25(10):1789-97. PubMed ID: 17229503
[TBL] [Abstract][Full Text] [Related]
11. Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from
Ozberk V; Reynolds S; Huo Y; Calcutt A; Eskandari S; Dooley J; Mills JL; Rasmussen IS; Dietrich J; Pandey M; Good MF
mBio; 2021 Feb; 12(1):. PubMed ID: 33622722
[TBL] [Abstract][Full Text] [Related]
12. Similar ability of FbaA with M protein to elicit protective immunity against group A streptococcus challenge in mice.
Ma CQ; Li CH; Wang XR; Zeng RH; Yin XL; Feng HD; Wei L
Cell Mol Immunol; 2009 Feb; 6(1):73-7. PubMed ID: 19254483
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX.
Jeng A; Sakota V; Li Z; Datta V; Beall B; Nizet V
J Bacteriol; 2003 Feb; 185(4):1208-17. PubMed ID: 12562790
[TBL] [Abstract][Full Text] [Related]
14. Mapping the fibrinogen-binding domain of serum opacity factor of group a streptococci.
Courtney HS; Dale JB; Hasty DL
Curr Microbiol; 2002 Apr; 44(4):236-40. PubMed ID: 11910491
[TBL] [Abstract][Full Text] [Related]
15. Clinical and microbiological response of mice to intranasal inoculation with Lactococcus lactis expressing Group A Streptococcus antigens, to be used as an anti-streptococcal vaccine.
García PC; Paillavil BA; Scioscia N; Dale JB; Legarraga P; Salazar-Echegarai FJ; Bueno SM; Kalergis AM; Wozniak A
Microbiol Immunol; 2018 Nov; 62(11):711-719. PubMed ID: 30357922
[TBL] [Abstract][Full Text] [Related]
16. SfbII protein, a fibronectin binding surface protein of group A streptococci, is a serum opacity factor with high serotype-specific apolipoproteinase activity.
Kreikemeyer B; Martin DR; Chhatwal GS
FEMS Microbiol Lett; 1999 Sep; 178(2):305-11. PubMed ID: 10499280
[TBL] [Abstract][Full Text] [Related]
17. DNA sequence of the serum opacity factor of group A streptococci: identification of a fibronectin-binding repeat domain.
Rakonjac JV; Robbins JC; Fischetti VA
Infect Immun; 1995 Feb; 63(2):622-31. PubMed ID: 7822031
[TBL] [Abstract][Full Text] [Related]
18. Serum opacity factor is a streptococcal receptor for the extracellular matrix protein fibulin-1.
Courtney HS; Li Y; Twal WO; Argraves WS
J Biol Chem; 2009 May; 284(19):12966-71. PubMed ID: 19276078
[TBL] [Abstract][Full Text] [Related]
19. The fibrinogen-binding M1 protein reduces pharyngeal cell adherence and colonization phenotypes of M1T1 group A Streptococcus.
Anderson EL; Cole JN; Olson J; Ryba B; Ghosh P; Nizet V
J Biol Chem; 2014 Feb; 289(6):3539-46. PubMed ID: 24356958
[TBL] [Abstract][Full Text] [Related]
20. Streptococcal opacity factor: a family of bifunctional proteins with lipoproteinase and fibronectin-binding activities.
Katerov V; Lindgren PE; Totolian AA; Schalén C
Curr Microbiol; 2000 Mar; 40(3):149-56. PubMed ID: 10679045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
